PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

ketoconazole

Verify with FDA → · CMS NADAC pricing →

Brand names: Nizoral

Azole Antifungal OTC

Ketoconazole shampoo is an antifungal medicine. It treats a fungal infection on your skin.

Drug Pricing (NADAC)

Generic Price

$0.16/unit

Generic Available

Yes (14 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

This shampoo treats tinea versicolor, a fungal infection.

Common side effects

No common side effects listed.

Key warnings

You should not use this shampoo if you are allergic to ketoconazole or any of the other ingredients.

How It Works

Ketoconazole is an antifungal medicine. It works by stopping the growth of the fungus. This helps to clear up the infection.

How to Take It

Apply the shampoo to the damp skin of the affected area and a wide margin around it. Lather the shampoo and leave it on for 5 minutes. Then, rinse it off with water. Usually, one application is enough.

Pregnancy & Breastfeeding

It is not known if ketoconazole shampoo can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding before using this medicine.

Missed Dose

Since you only use this once, you don't have to worry about a missed dose.

Storage

Store at room temperature, between 68° to 77°F. Protect from light.

Side Effects (from patient reports)

Based on 9,063 FDA adverse event reports.

The medicine did not work
1,582
Using the medicine for something it's not approved for
1,174
Feeling tired
929
Itching
902
Feeling sick to your stomach
834
Skin breakout
802
Loose stool
760
Aches
727
Head pain
708
A skin condition causing red, itchy, scaly patches
645

FDA Adverse Event Report Analysis

Detailed analysis of 16,231 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

16,231

Death-Related Reports

1,079

Hospitalization Reports

3,676

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 7,430 (51%)
Male 7,100 (49%)

Age Distribution

0–17 398
18–44 1,977
45–64 3,146
65–74 1,979
75+ 1,717

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 1,582
2 OFF LABEL USE 1,174
3 FATIGUE 929
4 PRURITUS 902
5 NAUSEA 834
6 RASH 802
7 DIARRHOEA 760
8 PAIN 727
9 HEADACHE 708
10 PSORIASIS 645
11 DYSPNOEA 601
12 DIZZINESS 589
13 PRODUCT USE IN UNAPPROVED INDICATION 548
14 ARTHRALGIA 541
15 CHRONIC KIDNEY DISEASE 520

Reactions in Death Reports

DEATH 415
OFF LABEL USE 79
RENAL FAILURE 78
PNEUMONIA 72
DYSPNOEA 65
ACUTE KIDNEY INJURY 60
DRUG INEFFECTIVE 57
ASTHENIA 55
NAUSEA 54
ANAEMIA 52

Reactions in Hospitalization Reports

DYSPNOEA 278
FATIGUE 276
PNEUMONIA 258
DIARRHOEA 248
NAUSEA 246
FALL 235
PAIN 234
ASTHENIA 232
ACUTE KIDNEY INJURY 205
DIZZINESS 203

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

You should not use this shampoo if you are allergic to ketoconazole or any of the other ingredients.

Known Drug Interactions

7 DRUG INTERACTIONS Concomitant use of PDE5 inhibitors with alpha adrenergic antagonists, including alfuzosin hydrochloride extended-release tablets, can potentially cause symptomatic hypotension ( 5.4 , 7.4) 7.1 CYP3A4 Inhibitors Alfuzosin hydrochloride extended-release tablets are contraindicated for use with potent CYP3A4 inhibitors such as ketoconazole, itraconazole, or ritonavir, since alfuzosin blood levels are increased [see Contraindications ( 4 ), Warnings and Precautions ( 5.4) and Clinical Pharmacology ( 12.3) ].

Mechanism: Ketoconazole blocks the enzyme that breaks down alfuzosin, which causes the amount of alfuzosin in your blood to rise to unsafe levels.

What to do: Do not take these two medicines together as the combination is unsafe.

7.2 Effects of Other Drugs on Dronedarone Ketoconazole and Other Potent CYP3A Inhibitors Concomitant use of ketoconazole as well as other potent CYP3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased [see Contraindications (4) , Clinical Pharmacology (12.3) ] .

Mechanism: Ketoconazole stops the liver enzyme that breaks down dronedarone from working. This causes dronedarone to build up to much higher levels in your body.

What to do: Do not use these medications at the same time. This combination is contraindicated by the manufacturer.

( 7.2 ) 7.1 Effects of Other Drugs on Ranolazine Strong CYP3A Inhibitors Do not use ranolazine with strong CYP3A inhibitors, including ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, and saquinavir [see Contraindications (4) , Clinical Pharmacology (12.3) ].

Mechanism: Ketoconazole stops the body from breaking down ranolazine, which can cause the drug to build up to unsafe levels in your blood.

What to do: Do not use these two medications together because the risk of side effects is too high.

7 DRUG INTERACTIONS Table 3: Clinically Relevant Interactions with QTERN Strong Inhibitors of CYP3A4/5 Enzymes Clinical Impact Ketoconazole significantly increased saxagliptin exposure. • Strong CYP3A4/5 Inhibitors (e.g., Ketoconazole): Do not coadminister QTERN with strong cytochrome P450 3A4/5 inhibitors.

Mechanism: Ketoconazole blocks the enzymes that clear saxagliptin from your body, which significantly increases the amount of drug in your blood.

What to do: Do not take these two medications at the same time.

7 DRUG INTERACTIONS Sildenafil can potentiate the hypotensive effects of nitrates, alpha blockers, and anti-hypertensives ( 4.1 , 5.5 , 7.1 , 7.2 , 7.3 , 12.2 ) With concomitant use of alpha blockers, initiate sildenafil at 25 mg dose ( 2.3 ) CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, erythromycin): Increase sildenafil exposure ( 2.4 , 7.4 , 12.3 ) Ritonavir: Do not exceed a maximum single dose of 25 mg in a 48 hour period ( 2.4 , 5.6 ) Erythromycin or strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, saquinavir): Consider a starting dose of 25 mg ( 2.4 , 7.4 ...

Mechanism: Ketoconazole slows down the breakdown of sildenafil, which can lead to higher levels of the drug in your system.

What to do: Your doctor should consider starting you on a lower dose of 25 mg of sildenafil.

Check all your medications →

Common Questions

How long will it take to see results?
It may take weeks or months for your skin color to return to normal after treatment.
Is tinea versicolor contagious?
No, tinea versicolor is not contagious.
Can tinea versicolor come back?
Yes, tinea versicolor can come back, even after treatment.
What should I do if the shampoo gets in my eyes?
Rinse your eyes thoroughly with water.
Can I use this shampoo on my face?
Talk to your doctor before using this shampoo on your face.
How often can I use this shampoo?
Usually, one application is enough. Talk to your doctor if you think you need to use it more often.
Can I use other skin products while using this shampoo?
Talk to your doctor or pharmacist before using other skin products with this shampoo.
What are the ingredients in this shampoo?
The shampoo contains ketoconazole and other ingredients. Ask your doctor or pharmacist for a complete list.
What does the shampoo look like?
Ketoconazole Shampoo, 2% is a red-orange color liquid.
Where is this medicine made?
This medicine is distributed by ANI Pharmaceuticals, Inc. in Baudette, MN.
Does ketoconazole interact with other medications?
Yes, ketoconazole has 113 known drug interactions. Notable interactions include alfuzosin, dronedarone, ranolazine. Always inform your doctor about all medications you are taking.
What drug class is ketoconazole?
ketoconazole belongs to the Azole Antifungal drug class. It is available over the counter (OTC). This shampoo treats tinea versicolor, a fungal infection.
Is ketoconazole safe during pregnancy?
It is not known if ketoconazole shampoo can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding before using this medicine. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Azole Antifungal

Other drugs grouped near ketoconazole — same-class peers and common alternatives.

Compare ketoconazole vs adapalene side-by-side →

Medication Guides

Related Health & Safety Data

What the FDA Data Shows for ketoconazole

The FDA label for ketoconazole (sold under brand names such as Nizoral) classifies it as an over-the-counter product in the Azole Antifungal class. This shampoo treats tinea versicolor, a fungal infection. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 9,063 voluntary reports. The database also lists 113 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.16.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: January 29, 2026

All federal data sources used on this page